TH155598A - Isoxazolines as therapeutic agents ISOXAZOLINES AS THERAPEUTIC AGENTS - Google Patents
Isoxazolines as therapeutic agents ISOXAZOLINES AS THERAPEUTIC AGENTSInfo
- Publication number
- TH155598A TH155598A TH1301006227A TH1301006227A TH155598A TH 155598 A TH155598 A TH 155598A TH 1301006227 A TH1301006227 A TH 1301006227A TH 1301006227 A TH1301006227 A TH 1301006227A TH 155598 A TH155598 A TH 155598A
- Authority
- TH
- Thailand
- Prior art keywords
- formula
- methyl
- salts
- isoxazolines
- oxo
- Prior art date
Links
- 239000003814 drug Substances 0.000 title claims abstract 4
- 150000002547 isoxazolines Chemical class 0.000 title 2
- 150000001875 compounds Chemical class 0.000 claims abstract 8
- 150000003839 salts Chemical class 0.000 claims abstract 6
- 239000011780 sodium chloride Substances 0.000 claims abstract 6
- 230000000975 bioactive Effects 0.000 claims abstract 4
- 150000004677 hydrates Chemical class 0.000 claims abstract 4
- 230000001900 immune effect Effects 0.000 claims abstract 4
- 239000002207 metabolite Substances 0.000 claims abstract 4
- 239000000126 substance Substances 0.000 claims abstract 4
- 238000002560 therapeutic procedure Methods 0.000 claims abstract 4
- -1 1- (2-cyclopropylamino) -2-oxoethyl Chemical group 0.000 claims 3
- XDCCFDLULQHNBS-UHFFFAOYSA-N 1,6-dihydropyridazine-3-carboxamide Chemical compound NC(=O)C1=NNCC=C1 XDCCFDLULQHNBS-UHFFFAOYSA-N 0.000 claims 1
- VFQXVTODMYMSMJ-UHFFFAOYSA-N Isonicotinamide Chemical compound NC(=O)C1=CC=NC=C1 VFQXVTODMYMSMJ-UHFFFAOYSA-N 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 229940079593 drugs Drugs 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 229940002612 prodrugs Drugs 0.000 abstract 1
Abstract
DC60 (15/11/56) การประดิษฐ์ปัจจุบันจัดเตรียมสารประกอบที่มีสูตร (I) (สูตรเคมี) สูตร (I) เมแทบอไลต์ที่มีฤทธิ์ทางชีวภาพ, โพร-ดรัก, ไอโซเมอร์,สเทอรี โอไอโซเมอร์, ซอลเวต, ไฮเดรต และเกลือของสิ่งเหล่านี้ที่สามารถยอมรับได้ทางเภสัชกรรม สารประกอบของการประดิษฐ์เป็น ประโยชน์สำหรับการบำบัดทางภูมิคุ้มกันวิทยา การประดิษฐ์ปัจจุบันจัดเตรียมสารประกอบที่มีสูตร (I) (สูตรเคมี) สูตร (I) เมแทบอไลต์ที่มีฤทธิ์ทางชีวภาพ, โพร-ดรัก, ไอโซเมอร์, สเทอรีโอโซเมอร์, ซอลเวต, ไฮเดรต และเกลือของสิ่งเหล่านี้ที่สามารถยอมรับได้ทางเภสัชกรรม สารประกอบของการประดิษฐ์เป็น ประโยชน์สำหรับการบำบัดทางภูมิคุ้มกันวิทยา สิทธิบัตรยา DC60 (15/11/56), the current invention provides a compound with formula (I) (chemical formula), formula (I), bioactive metabolites, prodrug, isomer, Stereosisomers, salvates, hydrates and salts of these are pharmaceutical acceptable. The compound of the invention is Benefits for immunological therapy The present invention provides compounds with formula (I) (chemical formula), formula (I) bioactive metabolites, prodrac, isomers, steriosomes. And salts, hydrates, and salts of these that are pharmaceutical acceptable. The compound of the invention is Benefits for immunological therapy, drug patents.
Claims (1)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TH155598A true TH155598A (en) | 2016-09-06 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2019007711A2 (en) | N- [4-fluoro-5 - [[(2s, 4s) -2-methyl-4 - [(5-methyl-1,2,4-oxadiazol-3-yl) methoxy] -1-piperidyl] methyl] thiazol-2-yl] acetamide as an oga inhibitor | |
| UY35998A (en) | 1- (3- (tert-BUTIL) 1- (p-TOLIL) -1H-PIRAZOL-5-IL) -3- (4 - ((2 - ((6-ETILPIRAZIN-2-IL) AMINO) PIRIDIN- 4-IL) METOXI) NAFTALEN-1-IL) UREA AND ITS PHARMACEUTICALLY ACCEPTABLE DERIVATIVE SALTS, AS INHIBITORS OF P38 M AP QUINASA | |
| RS54492B1 (en) | Apoptosis signal-regulating kinase inhibitor | |
| BR112014003237A2 (en) | indazole compounds, compositions and methods of use | |
| PE20170705A1 (en) | NEW COMPOUNDS AS RET INHIBITORS (REORGANIZED DURING TRANSFECTION) | |
| GT200900283A (en) | "COMBINATION THERAPY WITH A COMPOUND ACTING AS AN ADP PLAQUETARY RECEPTOR INHIBITOR". | |
| EA201000702A1 (en) | SOME DERIVATIVES 2-PYRAZINONE AND THEIR APPLICATION AS NEUTROFIL ELASTASIS INHIBITORS | |
| CR9432A (en) | DERIVED FROM BENCIMIDAZOL AND USE AS AN ANGONOTENSIN II ANTAGONIST | |
| CL2013000488A1 (en) | Co-crystals of compounds derived from (2r) -5-oxo-1- (benzylpiperidin-4-yl) -n- (pyridin-2-yl) pyrrolidin-2-carboxamide and a co-crystal forming agent; salts of the compounds; intermediary compounds; pharmaceutical composition; and its use for the treatment of inflammatory and infectious diseases. | |
| UA114325C2 (en) | PHENOXYETHYLPIPERIDINE COMPOUNDS | |
| TN2016000491A1 (en) | Carboxamide derivatives. | |
| PH12016502246B1 (en) | Carboxamide derivatives | |
| CL2020002550A1 (en) | Heteroaryl substituted pyrazole compounds and pharmaceutical use thereof. | |
| EA201170828A1 (en) | CONDENSED HETEROCYCLIC DERIVATIVES OF OXADIAZOL, SUITABLE FOR THE TREATMENT OF SCATTERED SCLEROSIS | |
| NZ631388A (en) | Phenyl-urea and phenyl-carbamate derivatives as inhibitors of protein aggregation | |
| AU2013260056A8 (en) | Compounds with TRPV4 activity, compositions and associated methods thereof | |
| ES2421587T3 (en) | Use of pyrimidylaminobenzamide derivatives for the treatment of systemic mastocytosis | |
| EA201691058A1 (en) | DERIVATIVES OF PYRROLOPIRROLON AND THEIR APPLICATION FOR THE TREATMENT OF DISEASES | |
| TH155598A (en) | Isoxazolines as therapeutic agents ISOXAZOLINES AS THERAPEUTIC AGENTS | |
| ECSP088988A (en) | DERIVATIVES OF PHENYLACTIC ACID | |
| PL420626A1 (en) | New derivatives of carbamates and their application | |
| AR054532A1 (en) | HETEROARILETENILO DERIVATIVES ITS OBTAINING AND USING AS PHARMACEUTICAL AGENTS | |
| NO20091862L (en) | N- (3-benzyl) -2,2- (bis-phenyl) -propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases | |
| RS54022B1 (en) | Viral inhibitor composition for in vivo therapeutic use | |
| TH167246A (en) | Biaryyl amide compounds As a kinase inhibitor |